PACS Group, Inc.
PACS- Exchange
- NYSE
- Industry
- Services-Skilled Nursing Care Facilities
- SEC CIK
- 0002001184
In the last 90 days, PACS Group, Inc. insiders filed 0 open-market purchases and 22 sales; 241 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:24 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Feb 26, 2026 | – |
| Revenue | $5.29B | $4.09B |
| Selling, general and administrative | $415.1M | $343.8M |
| Operating income | $309.6M | $123.1M |
| Income tax | $93.0M | $46.2M |
| Net income | $191.5M | $55.8M |
| EPS, basic | $1.23 | $0.38 |
| EPS, diluted | $1.22 | $0.38 |
| Weighted shares, basic | 156.2M | 146.7M |
| Weighted shares, diluted | 156.7M | 148.6M |
| Margins and growth | ||
| Operating margin | 5.9% | 3.0% |
| Net margin | 3.6% | 1.4% |
| Revenue growth, year over year | +29.3% | – |
| Net income growth, year over year | +243.5% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Feb 26, 2026 | – |
| Cash and equivalents | $197.0M | $157.7M |
| Accounts receivable | $628.1M | $641.8M |
| Total current assets | $1.07B | $938.3M |
| Goodwill | $61.8M | $60.8M |
| Total assets | $5.58B | $5.24B |
| Accounts payable | $192.2M | $175.1M |
| Short-term debt | $4.46M | $14.9M |
| Total current liabilities | $1.00B | $978.4M |
| Long-term debt | $244.8M | $251.0M |
| Total liabilities | $4.63B | $4.53B |
| Shareholders' equity | $952.4M | $715.7M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Feb 26, 2026 | – |
| Operating cash flow | $404.2M | $367.3M |
| Stock-based compensation | $54.1M | $115.5M |
| Dividends paid | $0 | $33.7M |
| Investing cash flow | -$264.0M | -$442.7M |
| Financing cash flow | -$69.0M | $117.5M |
| Net change in cash | $71.2M | $42.1M |
| Ratio | ||
| Stock-based compensation, % of revenue | 1.0% | 2.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.